Mobile Virtual Positive Experiences for Anhedonia (MVR)
Anhedonia, Virtual Reality, Depression
About this trial
This is an interventional treatment trial for Anhedonia focused on measuring Virtual Reality, Depression, Stress, Anxiety, Treatment
Eligibility Criteria
Inclusion Criteria:
- fluent in English
- below the population mean on either the Behavioral Activation Scale (BAS) Reward Drive subscale (score of ≤ 11), or BAS Responsiveness subscale (score of ≤16)
- score in mild-moderate range on DASS-21 following established score cutoffs: Depression (10-27); at least a score of Anxiety (8-14); and a score of at least Stress (15-25)
- Sheehan Disability Scale (SDS) overall score must be ≥ 6
- agree to refrain from initiating other psychosocial treatments throughout the duration of the study
Exclusion Criteria:
- Lifetime history of bipolar disorder, psychosis, intellectual disabilities, or organic brain damage
- substance use disorder in the past 6 months
- current use of psychotropic medications
- currently pregnant or planning to become pregnant
- self-reported frequent motion sickness, self-reported seizures within the last year and/or a diagnosis of epilepsy
Sites / Locations
- University of California, Los Angeles
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
Positive Virtual Reality Training Intervention
The control group will not undergo the positive virtual reality training program. Instead, they will complete all self-report and behavioral measures and have the option to experience the positive virtual reality training program upon the conclusion of the study.
The experimental group will undergo the positive virtual reality training program, which consists of 7 virtual reality (VR) sessions to be completed at home after orientation to the program, in addition to all self-report and behavioral measures.